Cargando…
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment
Defining feature of pancreatic ductal adenocarcinoma (PDAC) that participates in the high mortality rate and drug resistance is the immune-tolerant microenvironment which enables tumors to progress unabated by adaptive immunity. In this study, we report that PDAC cells release CSF-1 to induce nucleo...
Autores principales: | Amo-Aparicio, Jesus, Dominguez, Adrian, Atif, Shaikh M., Dinarello, Alberto, Azam, Tania, Alula, Kibrom M., Piper, Miles, Lieu, Christopher H., Lentz, Robert W., Leal, Alexis D., Bagby, Stacey M., Messersmith, Wells A., Karam, Sana D., Dinarello, Charles A., Pitts, Todd M., Marchetti, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510589/ https://www.ncbi.nlm.nih.gov/pubmed/37772994 http://dx.doi.org/10.1158/2767-9764.CRC-23-0065 |
Ejemplares similares
-
Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson’s disease
por: Amo-Aparicio, Jesus, et al.
Publicado: (2023) -
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression
por: Tengesdal, Isak W., et al.
Publicado: (2021) -
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
por: Marchetti, Carlo, et al.
Publicado: (2018) -
WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma
por: Hartman, Sarah J., et al.
Publicado: (2021) -
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
por: Lonnemann, Niklas, et al.
Publicado: (2020)